MEDIAN Technologies provides advanced medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development.
Since its inception, the company has developed a strong expertise in medical image processing. Based on industrial and research partnerships, and on its presence in more than 100 imaging departments of major cancer centers and health care institutions worldwide, the company provides innovative and enabling solutions for image interpretation and management, targeted to :
the oncology clinical trials market
the cancer patient care market
The company currently has a staff of over 45 highly skilled individuals who are committed to the company’s mission of making a dramatic impact on cancer care and research. More than half of the staff works in R&D and service-related activities. The team includes different scientific and/or technical backgrounds and expertise in image processing, data management, project management, business development, regulatory compliance, and general corporate management.
New White Paper – Innovations in Cancer Screening There has been great progress in the diagnosis and treatment of cancer in recent years, driven largely by the increased use of medical imaging technologies. As the world’s population ages, the number of new cases of cancer is set to rise — to 21.7 mi…